Kids & teens (for parents) · Wisconsin
Studies for children and teens in Wisconsin
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
25 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
NeuroTrainer Cognitive Training For Academic Focus
NeuroTrainer
- Location
- Madison, WI + 2 other US sites
- Eligibility basics
- Ages 11–17
- RecruitingPhase 3
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
H. Lundbeck A/S
- Location
- Milwaukee, WI + 13 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
H. Lundbeck A/S
- Location
- Milwaukee, WI + 8 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Vericel Corporation
- Location
- Milwaukee, WI + 10 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
Tyra Biosciences, Inc
- Location
- Madison, WI + 11 other US sites
- Eligibility basics
- Ages 3–10
- RecruitingPhase 3
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
GlaxoSmithKline
- Location
- Milwaukee, WI + 18 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Regeneron Pharmaceuticals
- Location
- Milwaukee, WI + 12 other US sites
- Eligibility basics
- Ages 6 mo–6
- RecruitingPhase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pfizer
- Location
- Kenosha, WI + 69 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Pfizer
- Location
- Madison, WI + 54 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- Madison, WI + 65 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Bristol-Myers Squibb
- Location
- Milwaukee, WI + 4 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Takeda
- Location
- Milwaukee, WI + 10 other US sites
- Eligibility basics
- Ages 4–17
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Madison, WI + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Donidalorsen Treatment in Children With Hereditary Angioedema
Ionis Pharmaceuticals, Inc.
- Location
- West Allis, WI + 7 other US sites
- Eligibility basics
- Ages 2–11
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Milwaukee, WI + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
QED Therapeutics, a BridgeBio company
- Location
- Madison, WI + 2 other US sites
- Eligibility basics
- Ages 0 mo–2
- RecruitingPhase 2
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Merck Sharp & Dohme LLC
- Location
- Milwaukee, WI + 8 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 2
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
Ascendis Pharma A/S
- Location
- Madison, WI + 2 other US sites
- Eligibility basics
- Ages 0 mo–2
- RecruitingPhase 3
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
ONY
- Location
- Madison, WI + 9 other US sites
- Eligibility basics
- Ages 7 mo–8 mo
- RecruitingHealthy volunteers
The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study
University of Wisconsin, Madison
- Location
- Madison, WI
- Eligibility basics
- Up to age 17
- RecruitingHealthy volunteers
Healthy Little Eyes
University of Wisconsin, Madison
- Location
- Madison, WI
- Eligibility basics
- Up to age 3
- RecruitingHealthy volunteers
Biomarkers Study in Infants With Prior Neonatal Brain Injury
University of Wisconsin, Madison
- Location
- Madison, WI
- Eligibility basics
- Ages 4 mo–2
- RecruitingHealthy volunteers
Sparking Potential, Revealing Infant Neurocognitive Traits
University of Wisconsin, Madison
- Location
- Madison, WI
- Eligibility basics
- Ages 4 mo–2
- RecruitingHealthy volunteers
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Medical College of Wisconsin
- Location
- Milwaukee, WI
- Eligibility basics
- Up to age 1